HER2 Detection Kit
HER2 Detection Kit
| Product | Detection Target Combination | Approved Drugs (Cancer Types) | Clinical Trial Drugs (Cancer Types) |
|---|---|---|---|
| HER2 Detection Kit | HER2 | Trastuzumab deruxtecan (DS-8201): HER2 breast cancer, gastric cancer, lung cancer, non-small cell lung cancer（NSCLC） RuiKang Trastuzumab (SHR-A1811): HER2 Non-Small Cell Lung Cancer, Biliary Tract Cancer (Planned Breakthrough Therapy in 2025) |
B-1701 (Beliscakin): HER2 Breast Cancer/NSCLC (Phase III) SHR-A2009 (Hengrui): HER3/HER2 dual targets, EGFR-mutant lung cancer (Phase II) RC48 (Aidixi): HER2 gastric cancer, urothelial carcinoma (Phase III) |
